DelveInsight's Short Bowel Syndrome Market Insights report includes a comprehensive understanding of current treatment practices, short ...
This new IP supports crofelemer's global exclusivity in rare pediatric intestinal failure coincident with published clinical ...
A generic teduglutide reduced parenteral nutrition requirements in 96% of pediatric patients within 24 weeks in clinical ...
Crofelemer can potentially extend lives of MVID patients – infants and children who face the lethal natural history of the disease Parenteral support reduction of up to 37% is groundbreaking; No ...
After spending the majority of her life in the hospital, Annaliese Holland is now preparing to end life “on my own terms” ...
Survival for babies under 600 grams is a testament to modern neonatal intensive care. Advanced medical interventions, ...
Jaguar Health, Inc. ( JAGX) Q3 2025 Earnings Call November 17, 2025 8:30 AM EST Greetings, and welcome to the Jaguar Health's Investor Webcast. [Operator Instructions] As a reminder, this conference ...
Crofelemer can potentially extend and save lives of microvillus inclusion disease patients, reducing the volume of the total parenteral support (PS) necessary for them to survive Groundbreaking PS ...
Knowing that her life will end, the 25-year-old said she has decided to “die on my own terms” with voluntary assisted dying ...
Request To Download Free Sample of This Strategic Report @ In 2018, the Clinical Nutrition Market reached a valuation of $313.578 billion, indicating a robust foundation for growth. Over the forecast ...
Q3 2025 Earnings Call Transcript November 12, 2025 CorMedix Inc. beats earnings expectations. Reported EPS is $1259.23, ...
The live event and accompanying slides can be accessed by visiting https://protara-therapeutics-update-call.open-exchange.net/registration, or via the Events and Presentations section of the Company’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback